Introduction
Signalling through LT␤R and TNFR55 is essential for development of peripheral lymphoid organs, such as lymph nodes and Peyer's patches, and for establishment of correct compartmentalisation of the spleen (for review see Fu and Chaplin 1 ). In the spleen the underlying molecular pathways have been partly dissected using mice deficient in tumour necrosis factor (TNF), lymphotoxin (LT) or their receptors (reviewed in Chaplin and Fu 2 ) and suggested defective expression of certain genes by stromal cells 3 in response to signalling by B lymphocytes expressing TNF and LT␣/LT␤. 4, 5 All these mice show deficiency in their immune response. 1 The downstream genes directly affected by disrupted signalling in lymphotoxin and TNF deficiency are largely unknown.
We used subtractive cloning to identify genes whose expression is substantially decreased in the spleens of TNF/LT deficient mice. By this method we have identified a novel homologue of phospholipase A 2 6,7 SPLASH (for secretory type PLA, stroma-associated, homologue) which is predominantly expressed in peripheral lymphoid organs and whose overall transcriptional level is substantially reduced in spleens of TNF/LT␣, and LT␣, but not of TNF deficient mice. SPLASH is also expressed in the thymus, but in this case there are no differences in expression levels between wild-type and mutant mice. SPLASH gene maps to the region of frequent allelic losses at the distal part of chromosome 4. This region contains two candidate cancer-related loci, Thymic Lymphoma Supressor Region 3 (TLSR3) 8 and MOM-1 (modifier of multiple intestinal neoplasia) locus. 9 The human SPLASH gene was also cloned and it maps to 1p35-36.1, the region known for frequent loss of heterozygosity in a variety of human cancers.
Results

Cloning of SPLASH
To identify genes whose function may be essential for the development of splenic structures that are lost in LT␣ and TNF/LT␣ deficient mice, we applied subtractive cDNA cloning. Poly A + mRNA was isolated from spleens of Tnf/Lta double knock-out mice 10 as well as from their littermate wild-type (WT) controls. In order to clone genes whose expression was substantially lower or absent in the mutant mice, subtraction was performed in an excess of cDNA from wild-type mice. The particular protocol used here (see Materials and methods) resulted in partial cDNA clones with inserts of different lengths. Individual inserts were sized on agarose gels, purified, labelled and used for Northern analysis of polyA + mRNA isolated from spleens of wild-type as well as of knockout mice. The labelled insert of one such clone hybridized to two mRNA bands of 1.2 and 2.2 kb and both showed six-fold difference between WT and LT␣ deficient mice and no difference between WT and TNF deficient mice ( Figure 1a) . The 900 bp insert was sequenced using vector-specific primers and its sequence used for gene identification. BLASTX search (which compares a nucleotide query sequence translated in all reading frames against protein sequence database) identified the sequence as a partial cDNA for a putative novel homologue of secretory type phospholipase A 2 (for review see Balsinde et al 11 and Murakami et al 12 ). Since this clone contained only a partial cDNA and lacked consensus polyadenylation signal, we proceeded to clone the full-length cDNA from a splenic cDNA library prepared from 129 × C57BL/6 mice. Several positive clones were isolated, and divided into two distinct groups based on their insert lengths. The complete sequences of two representative clones are shown in Figure 1b . The shorter cDNA apparently corresponded to the lower 1.2 kb band observed on Northern blots with 900 bp probe. The longer cDNA sequence was 1.8 kb and contained a B1 repeat at the 3′-end, suggesting that during synthesis cDNA could be primed from the internal polyA stretch of the B1 repeat. Based on the genomic sequence analysis (see below), it was later concluded that this incomplete clone corresponded to the 2.2 kb band observed on Northern blots. Although the main difference between 1.2 and 1.8 kb clones was in their 3′-untranslated sequences, they also differed in their 5′ regions (upstream of the ATG codon of the longer transcript, see Figure 1b) .
Alignment of the open reading frames from these cDNAs to sequences of previously characterised phospholipases A 2 showed 50% identity and 61% homology with PLA 2 group II, and, in particular, demonstrated conservation of all 14 cysteine positions ( Figure 2 ). The putative precursor protein of 144 aa and putative secreted protein of 125 aa contained features, such as C-terminal extension of six amino acids that terminated with a cysteine, making it a member of the mammalian group II PLA 2 . 7 These features suggested that the new gene is a homologue of 14 kD PLA 2 , being most closely related to human PLA 2 IIa and its murine counterpart, mPLA 2 IIa. The gene and its product were therefore called SPLASH (secretory type PLA, splenic, homologue, see below).
Since SPLASH was cloned using mice with combined TNF/LT␣ deficiency, 10 it was not clear initially whether its expression may be inversely associated with LT deficiency, with TNF deficiency, or with both. However, SPLASH cDNA was subsequently independently cloned by similar subtraction between splenic cDNA from the wild-type and Lta knock-out mice, suggesting that lower splenic expression of SPLASH is a feature associated with LT␣ deficiency. Interestingly, as for several other genes coming out of this screen, decreased splenic expression of SPLASH was observed only in Lta KO mice (and in Tnf/Lta KO mice), but not in Tnf KO (Figure 1a 
SPLASH is preferentially expressed in peripheral lymphoid tissues
To determine tissue specificity of SPLASH expression, Northern blot analysis was performed on polyA + mRNA isolated from various murine tissues. SPLASH showed maximal levels of expression in spleen and lymph nodes (Figure 3a ,b), with appreciable levels of expression in thymus, pancreas (data not shown), kidney, and lung and virtually no expression in other tissues. Messenger RNA for PLA 2 IIa, the closest homologue of SPLASH, showed the highest level of expression in smooth muscle.
SPLASH is expressed in cells from splenic white pulp, but not in lymphocytes
In order to determine the cell type expressing SPLASH in spleens, we used in situ hybridization. This analysis was performed on serial sections of spleens from naïve and SRBC immunized wild-type and Lta KO mice and clearly identified individual cells and cell clusters scattered throughout the white pulp with substantial expression of SPLASH. There was no co-localization to either T or B cell areas as determined by immunohistochemical labelling ( Figure 4) . Moreover, the cell morphology and overall hybridization pattern suggested that SPLASH was expressed either by stroma-associated cells or by dendritic cells, but not follicular dendritic cells. This is consistent with the observation that lymphocytes prepared from splenic cell suspension do not express appreciable levels of SPLASH (data not shown). In situ hybridization also suggested that the number of positive cells was significantly lower in Lta KO mice in comparison with wild-type mice, but the staining intensity of rare single positive cells was almost the same in KO and wt spleens. One possible interpretation of these findings is that SPLASH-expressing cells are not efficiently recruited to spleens of LT-deficient mice.
SPLASH is expressed in adult but not embryonic spleen
In order to address possible correlation with formation and function lymphoid organs we determined SPLASH mRNA expression in spleens at different stages of embryogenesis and postnatally ( Figure 5 ). Quantitative analysis indicated that SPLASH mRNA was almost undetectable in spleens of early and late embryos (up to day 18-19, data not shown). Weak expression of SPLASH was detected 1 week after birth, with further increase to normal levels by 4-6 weeks after birth. We concluded that the timing of splenic SPLASH expression correlated with the development of a mature immune system. Structure of the chromosomal gene suggests the existence of multiple transcripts and alternative splice forms of SPLASH To determine whether the two major transcripts of 1.2 kb and 1.8 kb (presumably truncated form of the 2.2 kb transcript, see above) originated from one or two distinct chromosomal genes, we probed genomic DNA with the 900 bp SPLASH probe. Single bands were visualised in most of the single restriction nuclease digests, suggestive of a unique chromosomal gene encoding SPLASH (data not shown). We then screened the murine genomic library and isolated several recombinant phage clones with high homology to SPLASH cDNA. Sequence analysis of these clones (accession No. AF188624) allowed con- + mRNA from wild-type, TNF, and LTa deficient mice were subjected to Northern blot analysis with 900 bp probe (Materials and methods). Equal loading was verified by GAPDH probe. (b) Sequence of two forms of SPLASH cDNA. Numbering starts from 1st nucleotide of the 1.8 (2.4) kb clone. The 5′ untranslated sequence in the shorter 1.2 kb clone that differs between two mRNAs is underlined. Putative translational start and stop codons, and polyadenylation signal are in bold type. Exon-intron junctions (based of genomic sequences, see Figure 5 ) and the 3′-end of the 1.2 kb clone are shown by arowheads. The B1 repetitive element at the end of 2.2 kb clone is in Italic. Deduced amino acid sequence is shown under nucleotide sequence in uppercases. The conserved cysteines are underlined. GeneBank accession numbers of these sequences are AF169407, AF169408, and AF188624. struction of a consistent map of a single genomic locus for SPLASH ( Figure 6 ) which suggested that both transcripts originate from the same gene as a result of alternative splicing or alternative promoter usage. The SPLASH gene contains 5 exons with most of the protein-coding sequence located in the longest 5 exon and with alternative usage of exons 1 and 2 in 1.8 (2.2) kb and 1.2 kb mRNA, respectively. These two alternative transcripts also differ in their non-coding 3′-ends with 1.2 kb mRNA being terminated prior to B1 repeat in the 3′-untranslated region (UTR) having consensus polyadenylation signal, while the 2.2 kb transcript extended further to the 3′-end of the B1 repeat. BLAST search of EST database identified one EST (gb:AI662740) with 100% identity to genomic sequence just downstream of B1 repeat of SPLASH with polydA track on its 3′-end and with consensus polyadenylation signal. This allowed us to reconstitute full cDNA sequence of 2166 bp which is in good agreement with the size of the high molecular weight band on Northern blots (see Figure 1a) .
Cloned chromosomal genes for other PLA 2 s contain 4-5 exons but their overall configuration seems to be different from one shown in Figure 6 .
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The SPLASH gene is located on murine chromosome 4 and on human chromosome 1, in close proximity to cancer-related loci Chromosomal location of the SPLASH locus was determined using a PCR-based technique and a commercial panels of murine/hamster and human/hamster radiation hybrid cells. Primers for murine SPLASH were designed that could only amplify genomic DNA (see Materials and methods). This linkage analysis mapped murine SPLASH to distal part of murine chromosome 4 between markers D4Mit310 and D4Mit158 (2.74 cR from D4Mit158, lod Ͼ 3.0). Similar analysis placed the human gene to 1p35-36.1, 5.23 cR from WI-5273 and 0.2 cR from WI-8651 (LOD Ͼ 7). Both human and mouse genes are in the regions where three other PLA 2 genes are located.
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Within the precision of mapping, the same region of murine chromosome 4 contains two cancer-related genetic loci, TLSR3 8 and Mom-1. 
Discussion
Phenotype of TNF/LT␣ and LT␣ deficient mice have embryonic component resulting in the lack of developed lymph nodes, as well as defects in splenic architecture. The latter, but not the former, component can be rescued by bone marrow transfer from wild-type mice, suggesting the plasticity of splenic phenotype in these mice presumably associated with altered gene expression spleen, that may be a consequence of disrupted signalling or may reflect impaired recruitment of certain cell types to lymphoid organs (for review see Fu and Chaplin 1 ). By searching for genes whose expression in spleen is inversely associated with splenic phenotype in TNF/LT␣ and LT␣ deficient mice, we cloned a cDNA encoding a novel murine secretory type phospholipase A 2 , which we call SPLASH (secretory type PLA, splenic, homologue). SPLASH is expressed mainly in peripheral lymphoid tissues, such as spleen and lymph nodes and to a lesser extent in other organs, such as thymus, pancreas and lung. In spleen SPLASH, along with several other genes isolated by the same procedure (Shakhov et al, manuscript in preparation), is expressed by dendritic cells or stroma-associated cells of lymphatic tissues, and not by lymphocytes. Interestingly, in mice with TNF/LT␣ and LT␣ deficiencies SPLASH expression is decreased in the spleen but not in the thymus (data not shown), consistent with the hypothesis that the overall lower expression of SPLASH is associated with impaired recruitment of certain cell types to spleen. Indeed, recent studies provided evidence that NK cells 16 and dendritic cells 17 show poor recruitment to spleens of LT␣-deficient mice.
Phospholipases A 2 (EC 3.1.1.4 ) constitute a large family of enzymes which catalyse the release of fatty acids from glycero-3-phosphocholines. The PLA 2 family contains at least nine groups and therefore constitutes a large gene family, mRNAs of many of its members are ubi- + mRNA from testis and pancreas were eliminated from analysis because of its integrity quality) (a) or Lta KO (KO) and WT littermate control mice (WT) (b) were separated in agarose geles (see Materials and methods) and hybridized with indicated probes. GAPDH probe was used for loading control. quitously expressed. The best known examples are digestive enzymes secreted as zymogens by the pancreas, this group of enzymes is closely related to snake venom phospholipases. Other forms of PLA 2 have been isolated from brain, liver, lung, spleen, intestine, macrophages, leukocytes, erythrocytes, inflammatory exudates, chondrocytes, and platelets. Besides their enzymatic roles, sPLA 2 can bind and signal through specific cellular receptors 18 (see also Lambeau and Lazdunski 19 for review). Additionally, a cytoplasmic PLA 2 has been directly implicated in the intracellular signalling cascade triggered by TNF via TNFRp55. 11, 12 No link between any PLA 2 and LT␤R signalling has been previously reported.
The chromosomal copy of SPLASH gene has been characterised and showed interesting features. The gene is transcribed as two distinct major mRNAs. Because the two forms of SPLASH mRNA show no homology at their 5′-ends, it is likely that these two transcripts originated from separate promoters. The 'out-of-frame' upstream ATG codon (the first ATG shown in bold in the shorter clone, Figure 1 ) is found to be in a non-optimal nucleoGenes and Immunity tide context and may provide only a poor translational start site. 20 As a consequence, the shorter 1.2 kb transcript encodes a protein without secretory signal peptide and that this protein presumably remains intracellular. However, it should be pointed out that one of the known SPLASH homologues, PLA 2 IIa, was reported to be a membrane-associated protein of mitochondria in rats 21 even though its gene contains a sequence for a putative signal peptide and can be secreted when overexpressed in vitro. 22 The murine SPLASH gene is located at the distal part of murine chromosome 4, and the human gene at 1p35-36.1, the region known for frequent loss of heterozygosity in a variety of human tumors. Loss of heterozygosity observed in X-ray induced T-cell lymphomas in C57BL/6J × RF/J F1 hybrid mice was previously linked to thymic lymphoma suppressor loci (TLSR 3), at the distal part of chromosome 4. These loci lie between chromosomal markers D4Mit54 and D4Mit13, 8 ie, in the same region as SPLASH.
Additionally, a dominantly transmitted mutation called Min (for multiple intestinal neoplasia) that causes a phenotype closely resembling familial adenomatous polyposis (FAP) has been identified. 23 The Min mice carry a nonsense mutation in one allele of the mouse homologue of FAP gene, 24 while homozygous Min mutation is lethal. Heterozygotes with the Min mutation developed numerous intestinal and colon adenomas similar in morphology to the adenomas seen in humans. It has been noted that the number of tumors is dependent on a second genetic locus, called MOM-1 (modifier of multiple intestinal neoplasia), which maps to a distal portion of chromosome 4. 14 Overexpression of PLA 2 IIa (Pla2g2a) in these mice resulted in reduction in tumor numbers and size [25] , suggesting that PLA 2 IIa may provide resistance to intestinal tumorigenesis. The homologous gene in the human, PLA 2 IIa, maps to 1p35-36.1, however its role in cancer has not been demonstrated.
When this manuscript was in preparation and under review, two groups 26, 27 reported cloning of cDNA for group IID sPLA gene based on database searches. The sequences for open reading frame in both cases encode enzymatically active sPLA2 and are coinciding with 1.2 kb transcript of murine SPLASH gene (Figure 1) . Our study provides the link between this activity and functional deficiency in the animal model. 
Materials and methods
Mice
Lta KO mice and mice with combined TNF/LT␣ deficiency were described previously. 10, 28 TNF/LT␣ mice were on mixed C57BL/6-sv129 background. Lta KO mice were purchased from Jackson Laboratory (Bar Harbor, Maine, ME, USA) and backcrossed six times to C57BL/6 background. All mouse strains were maintained under specific pathogen free conditions.
RNA preparation
Spleens were frozen in liquid nitrogen and then ground with a pestle in a pre-cooled mortar to obtain powdered tissue homogenate. Total cellular RNA was extracted with Trizol™ reagent (Gibco-BRL, Gaithersburg, MD, USA) and used for Northern analysis. Poly A + RNA for cDNA synthesis was prepared by using mRNA Separator from Clontech Laboratories, Inc. (Palo Alto, CA, USA), following the manufacturer's protocol.
Subtractive cloning
To identify mRNAs whose expression differed in spleens of wild-type (WT) and TNF/LT␣ double deficient mice Clontech PCR-Select™ cDNA Subtraction kit (Palo Alto, CA, USA) was used with the several modifications: (i) three hybrization 'time points' (18 h, 32 h, and 72 h) were combined before the 1st PCR reaction; (ii) after cloning into the BlueScript vector (Xma III -Eag I), clones were subjected to colony hybridization with gel purified products of the 2nd PCR reaction; and (iii) clones which appeared differentially positive in this test were purified and subjected to further Northern blot analysis.
Genes and Immunity
Northern blots
Ten g of total or 1 g of poly A
+ mRNA was separated on 1.5% denaturing agarose gel and transferred to Supported Nitrocellulose-1 (GibcoBRL) membrane. Hybridization with [ 32 P] labelled probes was performed in ExpessHyb™ solution (Clontech) and washed following the recommended protocol. Radioactivity was quantified using Molecular Dynamics screens and ImageQuant software.
cDNA and genomic cloning and sequencing A cDNA library was prepared from 10 g of poly A + mRNA from spleens of using the Stratagene ZAP Express XR Library construction Kit (La Jolla, CA, USA) according to the recommended protocol. After screening with [ 32 P] labelled probe and purification of individual phage clones, the plasmids containing the full-length SPLASH cDNA were rescued by excision. Commercial mouse genomic library (Stratagene, cat. No. 946313) was screened with the same probe. Purified phage DNA was sequenced in our on-site Core Sequencing Facility with primers designed on the basis of cDNA sequence. To complete genomic sequencing, additional primers were designed step-by-step based on already established structure. Custom oligonucleotides were purchased from Gibco-BRL.
cDNA cloning and sequencing of human SPLASH To clone human cDNA Stratagene Human Universal cDNA Library (La Jolla, CA, USA) cat. No. 937811 has been used with low stringent hybridization conditions (50°C) in ExpessHyb™ solution. After overnight hybridization membranes were washed three times for 30 min at 50°C in 2 × SSC, 1% SDS, once in 0.1 × SSC, 1% SDS at room temperature for 10 min, and expose o.n. to X-ray film with intensifying screen. Based on signal coordinates secondary membrane was subjected to screening following the above conditions. Clones corresponding to positive signals have been odered from Stratagene. To sequence the cDNA, primers were designed based on human EST sequences from public database with best homology to murine SPLASH cDNA.
Linkage analysis
DNA from mouse/hamster (T31 panel) and human/hamster (Genebridge4) radiation hybrids from Research Genetics (Huntsville, AL, USA) were generously provided by M Dean (NCI, Frederick, MD, USA). For higher specificity of PCR the primers in the case of murine gene were designed based on genomic rather than on the cDNA sequence of mouse SPLASH: 5′ oligo-CATTCTGAAGACTGAGATAGGA; 3′ oligo-CCTGG TATCACAGTGGATTC. Expected PCR fragment was 550 bp. For human SPLASH primers were chosen based on cDNA sequence to be able to segregate human and hamster PCR products by agarose gel: 5′ oligo-CTACGGCTGTCACTGCGGACTA; 3′ oligo-AAAGTT GTATCTGTAATAGTCCTTG. PCR fragments for human and hamster DNA were approximately 900 bp and 650 bp, respectively. PCR profile for both (human and mouse) mapping: 38 cycles with: 94°C, 30 s; 55°C, 30 s; 72°C 30 s. Linkage analysis was performed on-line on the server at the Whitehead Institute/MIT via Internet sites: http://www.genome.wi.mit.edu/cgi-bin/mouse rh/ rhmap-auto/rhmapper.cgi for mouse mapping and http://carbon.wi.mit.edu:8000/cgi-bin/contig/ rhmapper.pl for human mapping.
Immunohistochemical analysis
Frozen sections were prepared as described. 29, 30 Hamster antibodies to CD3␣ and rat antibodies to B220, and CR1 were from Pharmingen (San Diego, CA, USA). Biotinylated peanut agglutinin (PNA) and the alkaline phosphatase (AP) staining kit were purchased from Vector Laboratories, Inc (Burlingame, CA, USA). Peroxidaseconjugated mouse anti-rat IgG antibodies (F(ab) 2 fragment) were from Jackson ImmunoResearch Labs Inc (West Grove, PA, USA). AP-conjugated streptavidin and other reagents were from Sigma.
In situ hybridisation
Sections were prepared as above, fixed in 4% paraformaldehyde/PBS solution for 10 min at room temperature, washed three times with PBS, and were acetylated in 0.25% acetic anhydride for 10 min at room temperature. 31 After three washes in PBS, slides were prehybridized overnight in hybridization solution containing 50% formamide, 5 × SSC, 5 × Denhardt solution, 250 g/ml baker's yeast RNA, and 500 g/ml herring sperm DNA at room temperature. Hybridization was performed with dioxigenin (DIG) labelled antisense RNA (200-400 ng/ml) at 72°C prepared and purified using Boehringer Mannheim T7 kit (Indianapolis, IN, USA) according to the recommended protocol. After overnight hybridization, slides were washed in 0.2 × SSC for 3-4 hours at 72°C. Anti-DIG Ab conjugated with AP were applied after 1:2000 dilution in buffer B (0.1 m Tris-HCl (pH-7.6), 0.15 m NaCl) containing 1% heat inactivated sheep serum and incubated overnight at room temperature. After extensive washing in buffer B (3-5 times by 10 min) phosphatase reaction was performed in buffer B containing 50 mm MgCl 2 supplemented with 0.34 mg/ml NBT, 0.23 mg/ml BCIP, and 0.24 mg/ml levamisole (pH 9.5) for 3 h. All reagents for in situ hybridization, if not indicated otherwise, were purchased from Boeringer Mannheim (Indianapolis, IN, UA) .
